Related Experiment Videos

Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor

E Leygue1, H Dotzlaw, P H Watson

  • 1Department of Biochemistry and Molecular Biology, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba, Canada, R3EOW3. eleygue@cc.umanitoba.ca

Breast Cancer Research : BCR
|June 13, 2001
PubMed

Insights

Researchers studied estrogen receptor (ER)-alpha variant messenger RNA expression in breast tissues. Changes in ER-alpha variant expression were observed between normal and tumor tissues, potentially playing a role in breast cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Estrogen receptor (ER)-alpha is crucial in breast tissue function and its dysregulation is implicated in breast carcinogenesis.
  • Alternative splicing of ER-alpha leads to various variant messenger RNAs (ER variants) with potentially altered functions.
  • Understanding the expression patterns of ER-alpha variants in breast tumors is essential for elucidating breast cancer mechanisms.

Purpose of the Study:

  • To investigate the relative expression levels of different ER-alpha variant messenger RNAs compared to wild-type ER-alpha messenger RNA.
  • To compare ER-alpha variant expression in adjacent normal breast tissues versus matched breast tumor tissues.
  • To explore the potential role of altered ER-alpha variant expression in breast carcinogenesis.

Main Methods:

  • Utilized semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) assays.
  • Analyzed messenger RNA expression in paired normal and neoplastic breast tissue samples.
  • Quantified relative expression of specific ER-alpha variants, including ERC-4, ERD3, and ERD5.

Main Results:

  • A higher relative expression of ER-alpha variant (ERC-4) was observed in tumor tissues from ER-positive/PR-positive patients.
  • A lower relative expression of ER-alpha variant (ERD3) was found in tumor tissues from ER-positive patients.
  • Significantly increased relative expression of ER-alpha variant (ERD5) was detected in overall tumor tissues compared to normal tissues.

Conclusions:

  • Significant alterations in the relative expression of ER-alpha variant messenger RNAs occur between normal and neoplastic breast tissues.
  • These observed changes in ER-alpha variant expression may contribute to the molecular mechanisms driving breast cancer development.
  • Further research into ER-alpha variants could reveal novel therapeutic targets or biomarkers for breast cancer.

Related Concept Videos